96 related articles for article (PubMed ID: 10940511)
1. Chromosome aberrations as a predictor of clinical outcome for smoking associated lung cancer.
El-Zein R; Abdel-Rahman SZ; Conforti-Froes N; Alpard SK; Zwischenberger JB
Cancer Lett; 2000 Sep; 158(1):65-71. PubMed ID: 10940511
[TBL] [Abstract][Full Text] [Related]
2. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers.
Abdel-Rahman SZ; El-Zein RA; Zwischenberger JB; Au WW
Mutat Res; 1998 Feb; 398(1-2):43-54. PubMed ID: 9626964
[TBL] [Abstract][Full Text] [Related]
3. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer.
Zhu Y; Spitz MR; Strom S; Tomlinson GE; Amos CI; Minna JD; Wu X
Int J Cancer; 2002 Dec; 102(5):536-40. PubMed ID: 12432559
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities in chromosome 17 and p53 in lung carcinoma cells detected by fluorescence in situ hybridization.
Kawai T; Hiroi S; Nakanishi K; Sakurai Y; Torikata C
Pathol Int; 2004 Jun; 54(6):413-9. PubMed ID: 15144400
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients.
Dave BJ; Risin SA; Spitz MR; Pathak S
Anticancer Res; 1996; 16(3A):1187-92. PubMed ID: 8702234
[TBL] [Abstract][Full Text] [Related]
6. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers.
Conforti-Froes N; el-Zein R; Abdel-Rahman SZ; Zwischenberger JB; Au WW
Mutat Res; 1997 Sep; 379(1):53-9. PubMed ID: 9330622
[TBL] [Abstract][Full Text] [Related]
7. Chromosome aberrations in peripheral blood lymphocytes of lung cancer patients exposed to radon and air pollution.
Minina VI; Sinitsky MY; Druzhinin VG; Fucic A; Bakanova ML; Ryzhkova AV; Savchenko YA; Timofeeva AA; Titov RA; Voronina EN; Volobaev VP; Titov VA
Eur J Cancer Prev; 2018 Jan; 27(1):6-12. PubMed ID: 27232209
[TBL] [Abstract][Full Text] [Related]
8. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
9. Individuals at high risk for lung cancer have airway epithelial cells with chromosome aberrations frequently found in lung tumor cells.
Lechner JF; Neft RE; Gilliland FD; Crowell RE; Auckley DH; Temes RT; Belinsky SA
In Vivo; 1998; 12(1):23-6. PubMed ID: 9575422
[TBL] [Abstract][Full Text] [Related]
10. Detection of chromosomal aberrations in lung tissue and peripheral blood lymphocytes using interphase fluorescence in situ hybridization (FISH).
el-Zein RA; Abdel-Rahman SZ
Methods Mol Med; 2003; 75():145-61. PubMed ID: 12407739
[No Abstract] [Full Text] [Related]
11. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
Kapranos N; Kounelis S; Karantasis H; Kouri E
Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 5 aberrations and genetic predisposition to lung cancer.
Wu X; Zhao Y; Kemp BL; Amos CI; Siciliano MJ; Spitz MR
Int J Cancer; 1998 Oct; 79(5):490-3. PubMed ID: 9761118
[TBL] [Abstract][Full Text] [Related]
13. Cytokinesis-blocked micronucleus cytome assay and spectral karyotyping as methods for identifying chromosome damage in a lung cancer case-control population.
Lloyd SM; Lopez M; El-Zein R
Genes Chromosomes Cancer; 2013 Jul; 52(7):694-707. PubMed ID: 23630028
[TBL] [Abstract][Full Text] [Related]
14. Structural chromosomal aberrations as potential risk markers in incident cancer patients.
Vodenkova S; Polivkova Z; Musak L; Smerhovsky Z; Zoubkova H; Sytarova S; Kavcova E; Halasova E; Vodickova L; Jiraskova K; Svoboda M; Ambrus M; Hemminki K; Vodicka P
Mutagenesis; 2015 Jul; 30(4):557-63. PubMed ID: 25800034
[TBL] [Abstract][Full Text] [Related]
15. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
[TBL] [Abstract][Full Text] [Related]
16. [Cytogenetic analysis of lung tumors by in situ hybridization with chromosome-specific DNA probes].
Miyamoto H; Kato M; Ishikuro A; Akita H; Kawakami Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():33-8. PubMed ID: 1306236
[TBL] [Abstract][Full Text] [Related]
17. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
[TBL] [Abstract][Full Text] [Related]
18. Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma.
Wada Y; Igawa M; Shiina H; Shigeno K; Yokogi H; Urakami S; Yoneda T; Maruyama R
Br J Cancer; 1998 Jun; 77(11):2003-7. PubMed ID: 9667682
[TBL] [Abstract][Full Text] [Related]
19. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
Crowell RE; Gilliland FD; Temes RT; Harms HJ; Neft RE; Heaphy E; Auckley DH; Crooks LA; Jordan SW; Samet JM; Lechner JF; Belinsky SA
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):631-7. PubMed ID: 8824366
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer.
Jiang F; Caraway NP; Nebiyou Bekele B; Zhang HZ; Khanna A; Wang H; Li R; Fernandez RL; Zaidi TM; Johnston DA; Katz RL
Clin Cancer Res; 2005 Aug; 11(15):5417-24. PubMed ID: 16061856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
